Nektar Therapeutics
Ticker: NKTR
| Insider | Title |
|---|---|
| David Kroin | 10% or greater ownership |
| Diana Brainard | Director |
| Gil M Labrucherie | SVP, COO CFO |
| Howard W Robin | President CEO, Director |
| Jeffrey Robert Ajer | Director |
| Jillian B. Thomsen | Chief Financial Officer |
| John Northcott | SVP Chief Commercial Officer |
| Jonathan Zalevsky | Chief RD Officer |
| Karin Eastham | Director |
| Mark Andrew Wilson | Chief Legal Officer |
| Myriam Curet | Director |
| R Scott Greer | Director |
| Robert Chess | Director |
| Roy A Whitfield | Director |
| Sandra A. Gardiner | Chief Financial Officer |
| Track Biotechnology Master Fund, Ltd. Deep | 10% or greater ownership |
| Track Capital, Lp Deep | 10% or greater ownership |